{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fcovid-19-antiviral-agents-and-covid-19-rebound-98Vcum5v","width":444,"version":"1.0","type":"rich","title":"COVID-19 Antiviral Agents and COVID-19 Rebound","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/7a42ecbe-9a6a-43e9-bfcd-b93853a07bad/pod569-c19science-spotlight-2-0-ct-podcast-01.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/55e177a6-460e-482a-a19f-b816ef4c53b1\" height=\"200\" width=\"100%\" title=\"COVID-19 Antiviral Agents and COVID-19 Rebound\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Expert discussion of landmark clinical trials of COVID-19 antivirals for nonhospitalized patients and the COVID-19 rebound phenomenon. "}